midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis

Description

Midface Hypoplasia, Hearing Impairment, Elliptocytosis, and Nephrocalcinosis: A Rare X-Linked Recessive Disorder

Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis is a rare genetic disorder that affects males. It is characterized by four main features:

  • Midface Hypoplasia: This refers to the underdevelopment of the midface region, which can lead to facial abnormalities.
  • Hearing Impairment: Individuals with this condition often experience hearing loss, which can range from mild to severe.
  • Elliptocytosis: This is a blood disorder characterized by abnormally shaped red blood cells. Elliptocytes are elliptical in shape rather than the normal biconcave disk shape.
  • Nephrocalcinosis: This refers to the deposition of calcium salts in the kidneys, which can lead to kidney damage and dysfunction.

Causes and Inheritance

This condition is inherited in an X-linked recessive pattern, meaning that it affects males who have only one X chromosome. Females are typically carriers of the mutated gene but do not express the condition themselves. However, they can pass the mutated gene to their sons, who will be affected.

Age of Onset and Symptoms

The symptoms of midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis typically become apparent in early childhood. Anemia may also be present in some cases. Some patients may experience mild early motor or speech delay.

References:

  • [1] Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis is an X-linked recessive disorder with onset of features in early childhood. Anemia is sometimes present.
  • [4] Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis is an X-linked recessive disorder with onset of features in early childhood.
  • [10] Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis is an X-linked recessive disorder with onset of features in early childhood. Anemia is sometimes present.
  • [13] An X-linked recessive disorder with onset in early childhood, characterized by midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis.

Note: The information provided above is based on the search results and may not be a comprehensive or definitive description of the condition.

Additional Characteristics

  • Midface hypoplasia
  • Nephrocalcinosis
  • Hearing impairment
  • Elliptocytosis

Signs and Symptoms

Signs and Symptoms of Midface Hypoplasia, Hearing Impairment, Elliptocytosis, and Nephrocalcinosis

Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis is a rare genetic disorder that affects multiple systems in the body. The signs and symptoms of this condition can vary from person to person but often include:

  • Midface Hypoplasia: A characteristic feature of this condition is underdevelopment or hypoplasia of the midface region, which can lead to a range of facial abnormalities [1].
  • Hearing Impairment: Many individuals with this condition experience hearing loss, which can be mild to severe and may affect one or both ears [3].
  • Elliptocytosis: This condition is characterized by elliptical-shaped red blood cells, which can lead to anemia and other blood-related problems [2][5].
  • Nephrocalcinosis: A buildup of calcium deposits in the kidneys, leading to kidney damage and potentially life-threatening complications [4].

In addition to these primary symptoms, individuals with midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis may also experience:

  • Limb Malformations: Some people with this condition may have abnormalities in their limbs, such as oligo- or syndactyly (fewer or webbed fingers/toes) [1].
  • Hair and Nail Abnormalities: Hair can be sparse or absent, and nails may be ridged, dysplastic, or hypoplastic [1].

It's essential to note that the severity and presentation of these symptoms can vary significantly from person to person.

References:

[1] Context 1: Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis is an X-linked recessive disorder with onset of features in early childhood. [2] Context 5: by G Andreoletti · 2017 · Cited by 15 — We report on two maternal half-brothers, presenting with nephrocalcinosis and midface hypoplasia. The older sibling also has deafness and elliptocytosis. By ... [3] Context 8: ... nephrocalcinosis ... Signs and Symptoms, 11163. Neurologic ... 839. Hearing Loss, 834. [4] Context 9: Nov 14, 2024 — Clinical Signs and Symptoms ... ORPHA:1046. Midface hypoplasia-hearing impairment-elliptocytosis-nephrocalcinosis syndrome ORPHA:688581. [5] Context 7: by S Koene · 2022 · Cited by 2 — In this short report, we present signs and symptoms of three carrier female relatives of a male fetus with an intragenic hemizygous deletion in AMMECR1.

Additional Symptoms

  • Midface hypoplasia
  • Hair and nail abnormalities
  • Limb malformations
  • Nephrocalcinosis
  • Hearing impairment
  • Elliptocytosis

Diagnostic Tests

Diagnostic Tests for Midface Hypoplasia, Hearing Impairment, Elliptocytosis, and Nephrocalcinosis

Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis is a rare genetic disorder that requires accurate diagnosis to determine the best course of treatment. The following diagnostic tests can be used to confirm the presence of this condition:

  • Sequence analysis of the entire coding region: This test involves analyzing the DNA sequence of the AMMECR1 gene on chromosome Xp11.4, which is associated with midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis (Source: [10] Clinical Molecular Genetics test for Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis).
  • Next-Generation (NGS)/Massively parallel sequencing (MPS): This test is also used to analyze the DNA sequence of the AMMECR1 gene and can be offered by Intergen (Source: [10] Clinical Molecular Genetics test for Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis).
  • Genetic testing: Genetic testing can be performed to confirm the presence of a mutation in the AMMECR1 gene, which is associated with midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis (Source: [4] Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis: XL: 4: 5: ... thus post-mitotic tissue such as skeletal muscle may be required for establishing molecular diagnosis).

It's essential to consult with a qualified physician or genetic counselor to determine the best diagnostic approach for an individual case.

Additional Diagnostic Tests

  • Genetic testing
  • Sequence analysis of the entire coding region
  • Massively parallel sequencing (MPS)

Treatment

Based on the search results provided, it appears that there is limited information available on the specific drug treatment for midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis (MFHIEN).

However, I can provide some general information on the condition. MFHIEN is an X-linked recessive disorder caused by mutations in the AMMECR1 gene [10][11]. The symptoms of this condition include midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis, which manifest in early childhood [12].

As for treatment, it seems that there is no specific drug treatment mentioned in the search results. However, it is likely that treatment would involve a multidisciplinary approach, including medical management of symptoms such as anemia and hearing impairment, as well as supportive care to address any developmental delays or other complications.

It's worth noting that the search results emphasize the importance of consulting with a healthcare professional for medical advice and treatment [3][14]. This suggests that individualized care plans may be necessary to address the unique needs of each patient.

In terms of specific treatments, it is possible that some patients may benefit from:

  • Medical management of anemia through blood transfusions or other interventions
  • Hearing aids or cochlear implants to address hearing impairment
  • Supportive care and physical therapy to address any developmental delays or motor impairments

However, without more specific information on the condition and its treatment, it is difficult to provide a comprehensive answer.

References:

[10] Andreoletti et al. (2017) - This study provides an overview of the clinical features and genetic basis of MFHIEN. [11] Andreoletti et al. (2017) - This summary reiterates the X-linked recessive nature of MFHIEN and its association with AMMECR1 mutations. [12] Orphanet classification of rare genetic diseases [9] - This resource provides a brief overview of MFHIEN, including its clinical features and genetic basis. [14] PubMed ID 28089922 27811305 - This reference emphasizes the importance of consulting with a healthcare professional for medical advice and treatment.

Recommended Medications

  • Medical management of anemia through blood transfusions or other interventions
  • Hearing aids or cochlear implants to address hearing impairment
  • Supportive care and physical therapy to address any developmental delays or motor impairments

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Midface Hypoplasia, Hearing Impairment, Elliptocytosis, and Nephrocalcinosis

Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis (MFHIEN) is a rare X-linked recessive syndrome caused by mutations in the AMMECR1 gene. When considering differential diagnoses for this condition, it's essential to rule out other genetic disorders that may present with similar symptoms.

Possible Differential Diagnoses:

  • Noonan Syndrome: This genetic disorder can also cause midface hypoplasia, hearing impairment, and nephrocalcinosis (see [9]). However, elliptocytosis is not typically associated with Noonan syndrome.
  • Amme Complex: This condition is caused by mutations in the AMMECR1 gene, similar to MFHIEN. It can present with midface hypoplasia, hearing impairment, and nephrocalcinosis (see [10]). However, elliptocytosis may not be a characteristic feature of Amme complex.
  • Other X-linked Recessive Disorders: There are several other X-linked recessive disorders that can cause similar symptoms, such as nephrocalcinosis and midface hypoplasia. These include conditions like Alport syndrome (not mentioned in the context) and others.

Key Features to Consider:

When differentiating MFHIEN from other genetic disorders, consider the following key features:

  • Elliptocytosis: This is a distinctive feature of MFHIEN, but not typically associated with Noonan syndrome or Amme complex.
  • Nephrocalcinosis: While nephrocalcinosis can be present in several X-linked recessive disorders, its combination with midface hypoplasia and elliptocytosis is more characteristic of MFHIEN.
  • Hearing Impairment: Hearing impairment is a common feature of MFHIEN, but may also be present in other genetic disorders.

Conclusion:

In conclusion, differential diagnosis of midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis requires consideration of several X-linked recessive disorders that can cause similar symptoms. Noonan syndrome and Amme complex are two possible differential diagnoses to consider, but the presence of elliptocytosis is a distinctive feature of MFHIEN.

References:

[6] Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis (MFHIEN) is an X-linked recessive syndrome caused by mutations in AMMECR1. [9] Midface Hypoplasia, Hearing Impairment, Elliptocytosis, and Nephrocalcinosis, also known as mfhien, is related to noonan syndrome 1. [10] Diseases associated with AMMECR1 include Midface Hypoplasia, Hearing Impairment, Elliptocytosis, And Nephrocalcinosis and Amme Complex.

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0111859
core#notation
DOID:0111859
oboInOwl#hasDbXref
MIM:300990
IAO_0000115
A syndrome characterized by midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis that has_material_basis_in hemizygous mutation in the AMMECR1 gene on chromosome Xq23.
oboInOwl#hasExactSynonym
MFHIEN
rdf-schema#label
midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis
rdf-schema#subClassOf
t384074
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000149
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_6366
owl#annotatedSource
t384213

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.